Literature DB >> 20192890

Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients.

Mona Olofsson1, Kurt Boman.   

Abstract

OBJECTIVE: To explore the negative predictive value (NPV), positive predictive value (PPV), sensitivity, and specificity of natriuretic peptides, cut-off levels, and the impact of gender and age in elderly patients with systolic heart failure (HF).
DESIGN: Cross-sectional exploratory study.
SETTING: One primary healthcare centre. PATIENTS: A total of 109 patients with symptoms of HF were referred for echocardiographic examination with a cardiovascular consultation. Systolic HF was diagnosed (ESC guidelines) in 48 patients (46% men, 54% women, mean age 79 years) while 61 patients (21% men, 79% women, mean age 76 years) had no HF. MAIN OUTCOME MEASURES: NPV, PPV, sensitivity, specificity, and cut-off levels.
RESULTS: Including all 109 patients, NPV was 88% for NT-proBNP (200 ng/L) and 87% for BNP (20 pg/ml). PPV was 81% for NT-proBNP (500 ng/L) and 68% for BNP (50 pg/ml). Sensitivity was 96% for NT-proBNP (100 ng/L) and 96% for BNP (10-20 pg/ml). Specificity was 87% for NT-proBNP (500 ng/L) and 71% for BNP (50 pg/ml). Nt-proBNP (beta = 0.035; p < 0.001) and BNP (beta = 0.030; p < 0.001) were associated with age, but not with gender. In a multivariate analysis age (beta = 0.036; p < 0.001) and male gender (beta = 0.270; p = 0.014) were associated with NT-proBNP, but only age for BNP (beta = 0.030; p < 0.001).
CONCLUSION: Natriuretic peptides in an elderly population showed high NPVs, but not as high as in younger patients with HF in other studies. Age and male gender were associated with higher levels of NT-proBNP while only age was related to elevated BNP levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192890      PMCID: PMC3440611          DOI: 10.3109/02813430903345074

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  16 in total

1.  Diagnosis and management of heart failure: a questionnaire among general practitioners and cardiologists.

Authors:  Frans H Rutten; Diederick E Grobbee; Arno W Hoes
Journal:  Eur J Heart Fail       Date:  2003-06       Impact factor: 15.534

2.  Impact of age and sex on plasma natriuretic peptide levels in healthy adults.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Eric P Leip; Emelia J Benjamin; Peter W F Wilson; Patrice Sutherland; Torbjorn Omland; Ramachandran S Vasan
Journal:  Am J Cardiol       Date:  2002-08-01       Impact factor: 2.778

3.  N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.

Authors:  Georg Hess; Stefan Runkel; Dietmar Zdunek; Walter E Hitzler
Journal:  Clin Lab       Date:  2005       Impact factor: 1.138

4.  Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  1995-06       Impact factor: 29.983

5.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

Authors:  Karl Swedberg; John Cleland; Henry Dargie; Helmut Drexler; Ferenc Follath; Michel Komajda; Luigi Tavazzi; Otto A Smiseth; Antonello Gavazzi; Axel Haverich; Arno Hoes; Tiny Jaarsma; Jerzy Korewicki; Samuel Lévy; Cecilia Linde; José-Luis Lopez-Sendon; Markku S Nieminen; Luc Piérard; Willem J Remme
Journal:  Eur Heart J       Date:  2005-05-18       Impact factor: 29.983

Review 6.  [National and international guidelines ignore significant cause of heart failure. Diastolic dysfunction is often the cause of heart failure in the elderly and in women].

Authors:  B Fagerberg
Journal:  Lakartidningen       Date:  1998-11-18

7.  Can brain natriuretic peptide (BNP) be used as a screening tool in general practice?

Authors:  Maria Schaufelberger; Claes-Håkan Bergh; Kenneth Caidahl; Robert Eggertsen; Eva Furenäs; Göran Lindstedt; Thomas Nilsson; Kari Stefferud; Karl Swedberg
Journal:  Scand J Prim Health Care       Date:  2004-09       Impact factor: 2.581

Review 8.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur Heart J       Date:  2008-09-17       Impact factor: 29.983

9.  Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).

Authors:  A Bergström; B Andersson; M Edner; E Nylander; H Persson; U Dahlström
Journal:  Eur J Heart Fail       Date:  2004-06       Impact factor: 15.534

Review 10.  Clinical applications of B-type natriuretic peptide (BNP) testing.

Authors:  M R Cowie; P Jourdain; A Maisel; U Dahlstrom; F Follath; R Isnard; A Luchner; T McDonagh; J Mair; M Nieminen; G Francis
Journal:  Eur Heart J       Date:  2003-10       Impact factor: 29.983

View more
  4 in total

1.  Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review.

Authors:  Ronald A Booth; Stephen A Hill; Andrew Don-Wauchope; P Lina Santaguida; Mark Oremus; Robert McKelvie; Cynthia Balion; Judy A Brown; Usman Ali; Amy Bustamam; Nazmul Sohel; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

2.  Utility of NT-proBNP as a rule-out test for left ventricular dysfunction in very old people with limiting dyspnoea: the Newcastle 85+ Study.

Authors:  Joanna Collerton; Andrew Kingston; Fahad Yousaf; Karen Davies; Antoinette Kenny; Dermot Neely; Carmen Martin-Ruiz; Guy MacGowan; Louise Robinson; Thomas B L Kirkwood; Bernard Keavney
Journal:  BMC Cardiovasc Disord       Date:  2014-09-26       Impact factor: 2.298

3.  Diagnostic rules and algorithms for the diagnosis of non-acute heart failure in patients 80 years of age and older: a diagnostic accuracy and validation study.

Authors:  Miek Smeets; Jan Degryse; Stefan Janssens; Catharina Matheï; Pierre Wallemacq; Jean-Louis Vanoverschelde; Bert Aertgeerts; Bert Vaes
Journal:  BMJ Open       Date:  2016-10-06       Impact factor: 2.692

4.  Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure.

Authors:  Zeyu Wang; Xin Pan; Hong Xu; You Wu; Xiaomin Jia; Yiling Fang; Yi Lu; Yawei Xu; Ji Zhang; Yang Su
Journal:  Front Cardiovasc Med       Date:  2022-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.